Flynn James E 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-14 6:20 pm Sale | 2026-03-31 | 13G | COGENT BIOSCIENCES INC COGT | Flynn James E | 9,043,903 5.290% | -9,215 (-0.10%) | Filing |
| 2025-07-11 08:19 am Purchase | 2025-07-07 | 13G | COGENT BIOSCIENCES INC COGT | Flynn James E | 9,053,118 6.490% | 6,086,773 (+205.19%) | Filing |
| 2023-02-10 09:40 am Sale | 2022-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Flynn James E | 2,966,345 4.240% | -2,910,460 (-49.52%) | Filing |
| 2022-06-17 08:00 am Purchase | 2022-06-13 | 13G | COGENT BIOSCIENCES INC COGT | Flynn James E | 5,876,805 9.640% | 5,876,805 (New Position) | Filing |